Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease (CKD AGE)
Primary Purpose
Kidney Failure, Chronic, Chronic Kidney Disease stage3, Chronic Kidney Disease Stage 3B
Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Low-AGE diet
High-AGE diet
Sponsored by
About this trial
This is an interventional prevention trial for Kidney Failure, Chronic focused on measuring kidney failure, advanced glycation products, chronic kidney disease
Eligibility Criteria
Inclusion Criteria:
- Patients with a grade IIIA-B CKD (GFR with CKD-EPI ≥ 30 mL/min and < 60mL/min)
- Informed consent signed
- Aged 18 to 89 years
Exclusion Criteria:
- Protected adult
- Acute renal failure
- Patient already on a low-AGE diet (< 1kU AGE/day) following a dietetic consultation
- Current participation in another interventional research
Sites / Locations
- Centre Hospitalier Saint Joseph Saint Luc
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Normal-protein and low-AGE through raw or rare proteins diet
Normal-protein and AGE-rich diet
Arm Description
Normal-protein (0,8g/kg/day) and low-AGE through raw or rare proteins diet during 24 months
Normal-protein (0,8g/kg/day) and high-AGE through overcooked proteins diet during 24 months
Outcomes
Primary Outcome Measures
Glomerular Filtration Rate
Glomerular Filtration Rate estimated by the CKD-EPI formula with a blood sample
Secondary Outcome Measures
Proteinuria
Proteinuria (g/24h) found in the 24-hour urine
Full Information
NCT ID
NCT04827290
First Posted
March 30, 2021
Last Updated
January 3, 2022
Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon
1. Study Identification
Unique Protocol Identification Number
NCT04827290
Brief Title
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
Acronym
CKD AGE
Official Title
Assessment of the Effect of Restriction on Alimentary AGE (Advanced Glycation Products) in Progression of Chronic Kidney Disease (CKD)
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
August 1, 2022 (Anticipated)
Primary Completion Date
August 1, 2023 (Anticipated)
Study Completion Date
September 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Saint Joseph Saint Luc de Lyon
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Normal-protein and low-AGE through raw or rare proteins diet versus normal-protein and high-AGE diet in stage IIIa-b renal failure patients
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Kidney Failure, Chronic, Chronic Kidney Disease stage3, Chronic Kidney Disease Stage 3B, Chronic Kidney Disease Stage 3A (Disorder), Chronic Kidney Disease, Stage 3 (Moderate), Diet Habit
Keywords
kidney failure, advanced glycation products, chronic kidney disease
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
66 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Normal-protein and low-AGE through raw or rare proteins diet
Arm Type
Experimental
Arm Description
Normal-protein (0,8g/kg/day) and low-AGE through raw or rare proteins diet during 24 months
Arm Title
Normal-protein and AGE-rich diet
Arm Type
Active Comparator
Arm Description
Normal-protein (0,8g/kg/day) and high-AGE through overcooked proteins diet during 24 months
Intervention Type
Behavioral
Intervention Name(s)
Low-AGE diet
Intervention Description
Low-AGE diet during 24 months
Intervention Type
Behavioral
Intervention Name(s)
High-AGE diet
Intervention Description
High-AGE diet during 24 months
Primary Outcome Measure Information:
Title
Glomerular Filtration Rate
Description
Glomerular Filtration Rate estimated by the CKD-EPI formula with a blood sample
Time Frame
At 24 months
Secondary Outcome Measure Information:
Title
Proteinuria
Description
Proteinuria (g/24h) found in the 24-hour urine
Time Frame
At 24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with a grade IIIA-B CKD (GFR with CKD-EPI ≥ 30 mL/min and < 60mL/min)
Informed consent signed
Aged 18 to 89 years
Exclusion Criteria:
Protected adult
Acute renal failure
Patient already on a low-AGE diet (< 1kU AGE/day) following a dietetic consultation
Current participation in another interventional research
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fanny Doroszewski
Phone
0033478618398
Email
fdoroszewski@chsjsl.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Gabrielle Normand, MD
Email
lgnormand@chsjsl.fr
Facility Information:
Facility Name
Centre Hospitalier Saint Joseph Saint Luc
City
Lyon
ZIP/Postal Code
69007
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fanny Doroszewski
Phone
0033478618398
Email
fdoroszewski@chsjsl.fr
First Name & Middle Initial & Last Name & Degree
Gabrielle Normand, MD
Email
lgnormand@chsjsl.fr
First Name & Middle Initial & Last Name & Degree
Gabrielle Normand, MD
First Name & Middle Initial & Last Name & Degree
Emmanuel Villar, MD
First Name & Middle Initial & Last Name & Degree
Amélie Belloi, MD
First Name & Middle Initial & Last Name & Degree
Cecile Chauvet, MD
First Name & Middle Initial & Last Name & Degree
Mathilde Luce, MD
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Assessment of the Effect of Restriction on Alimentary AGE in Progression of Chronic Kidney Disease
We'll reach out to this number within 24 hrs